TVTX - What's Going On With Travere Therapeutics Stock? | Benzinga
Travere Therapeutics, Inc. (NASDAQ: TVTX) shares are trading higher Tuesday. The company announced several FDA regulatory updates after the market close on Monday.
The Details:
Travere Therapeutics announced the completion of a successful pre-NDA meeting with the FDA for Filspari. The company said that it will submit a supplemental New Drug Application (sNDA) in the first quarter ...